Literature DB >> 31667169

Feasibility of laparoscopic isolated caudate lobe resection for rare hepatic mesenchymal neoplasms.

Yang Li1, Kai-Ning Zeng1, Dan-Yun Ruan2, Jia Yao1, Yang Yang1, Gui-Hua Chen1, Gen-Shu Wang3.   

Abstract

BACKGROUND: Mesenchymal tumors such as perivascular epithelioid cell neoplasm (PEComa) and inflammatory pseudotumor-like follicular dendritic cell sarcoma (IPT-like FDC sarcoma) are relatively uncommon in the liver and are particularly rare in the caudate lobe. The clinical manifestations and available imaging tests lack specificity for hepatic mesenchymal tumors. To the best of our knowledge, no caudate PEComa or IPT-like FDC sarcoma has been completely resected by laparoscopy. The standard laparoscopic technique, surgical approaches, and tumor margins for potentially malignant or malignant caudate mesenchymal tumors are still being explored. AIM: To assess both the safety and feasibility of laparoscopic resection for rare caudate mesenchymal neoplasms.
METHODS: Eleven patients who underwent isolated caudate lobe resection from 2003 to 2017 were identified from a prospective database. Three consecutive patients with rare caudate mesenchymal tumors underwent laparoscopic resection. Patient demographic data, intraoperative parameters, and postoperative outcomes were assessed and compared with the open surgery group.
RESULTS: All procedures for the three resection patients with caudate mesenchymal tumors were completed using a total laparoscopic technique by two different approaches. The average operative time was 226 min, and the estimated blood loss was 133 mL. The average length of postoperative hospital stay was 6.3 ± 0.3 d for the laparoscopy group and 15.5 ± 2.3 d for the open surgery group (P < 0.05). There were no perioperative complications or patient deaths in this series.
CONCLUSION: Laparoscopic isolated caudate lobe resection for rare mesenchymal neoplasms is a feasible and curative surgical option in selected patients. ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Caudate lobe; Inflammatory pseudotumor-like follicular dendritic cell sarcoma; Laparoscopic liver resection; Perivascular epithelioid cell neoplasm

Year:  2019        PMID: 31667169      PMCID: PMC6819300          DOI: 10.12998/wjcc.v7.i20.3194

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


Core tip: Although laparoscopic liver resection is now considered a standard procedure in peripheral segments, there are a limited number of reports focused on laparoscopic caudate lobe resection. Perivascular epithelioid cell neoplasm and inflammatory pseudotumor-like follicular dendritic cell sarcoma are particularly rare mesenchymal neoplasms in the liver, especially in the caudate lobe. Laparoscopic resection provides better quality of care and shortens hospital stay relative to open surgery. For such rare mesenchymal neoplasms, laparoscopic isolated caudate lobe resection is a feasible and curative surgical option in selected patients.

INTRODUCTION

Hepatic mesenchymal tumors are neoplasms that arise from vascular, fibrous, adipose, and other mesenchymal tissue components[1]. Excluding hemangiomas, mesenchymal tumors such as perivascular epithelioid cell neoplasm (PEComa) and inflammatory pseudotumor-like follicular dendritic cell sarcoma (IPT-like FDC sarcoma) are relatively uncommon in the liver and are particularly rare in the caudate lobe. The clinical manifestations and available imaging tests lack specificity for hepatic mesenchymal tumors. Therefore, a correct diagnosis is made on the basis of morphologic characteristics and immunohistochemical results after resection or biopsy[2]. The caudate lobe has unique anatomy[3] and is considered the forbidden zone of laparoscopic hepatectomy. However, there have been sporadic attempts to apply the laparoscopic approach to the caudate lobe due to encouraging outcomes of laparoscopic liver resection and improved surgical experience[4-6]. However, to the best of our knowledge, no caudate PEComa or IPT-like FDC sarcoma has been completely resected by laparoscopy. The standard laparoscopic technique, surgical approaches, and tumor margins for potentially malignant or malignant caudate mesenchymal tumors are still being explored. In this study, we present three consecutive cases of caudate mesenchymal tumors (2 cases of PEComa and 1 case of IPT-like FDC sarcoma) completely resected by laparoscopy by two different approaches. We assessed the safety and feasibility of the procedure by comparing the outcomes to those of patients who underwent isolated caudate resection by open surgery.

MATERIALS AND METHODS

All patients who underwent isolated caudate lobe resection at our institution from 2003 to 2017 were identified in a prospective database, and their data were retrospectively reviewed. The patients who underwent isolated caudate lobe resection by laparoscopy were compared with those who underwent open surgery in terms of tumor characteristics, intraoperative characteristics, and postoperative outcomes.

Preoperative evaluation

The preoperative investigations included blood and liver function tests and routine cardiorespiratory evaluations. The imaging tests included enhanced computed tomography, magnetic resonance imaging, and ultrasound. There was no specific evaluation required for caudate lobe resection. However, special attention was given to the caudate pedicel and contact between the tumor and inferior vena cava (IVC) (Figure 1A, B and Figure 2A, B).
Figure 1

Combined approach to laparoscopic caudate inflammatory pseudotumor-like follicular dendritic cell sarcoma lobectomy. A and B: The tumor was located at the junction of the Spiegel’s lobe and the paracaval portion; C: The short hepatic vein was dissected; D: The feeding portal pedicle of the caudate lobe (arrow P); E: Isolation of the caudate lobe from right side; F: Surgical area after the tumor was resected; G: Microscopic appearance of caudate inflammatory pseudotumor-like follicular dendritic cell sarcoma (×200); H: Positive CD21 staining by immunohistochemistry (×200).

Figure 2

Left approach to laparoscopic caudate perivascular epithelioid cell neoplasm lobectomy. A and B: The tumor was located at the Spiegel’s lobe; C: Isolation of the caudate lobe from left side; D: Dissection of the feeding portal pedicle of the caudate lobe (arrow P); E: Isolation of the tumor (arrow T) and dissection of short hepatic vein (arrow SHV); F: Surgical area after the tumor was resected; G: Microscopic appearance of caudate perivascular epithelioid cell neoplasm (×200); H: Positive HMB-45 staining by immunohistochemistry (×200).

Combined approach to laparoscopic caudate inflammatory pseudotumor-like follicular dendritic cell sarcoma lobectomy. A and B: The tumor was located at the junction of the Spiegel’s lobe and the paracaval portion; C: The short hepatic vein was dissected; D: The feeding portal pedicle of the caudate lobe (arrow P); E: Isolation of the caudate lobe from right side; F: Surgical area after the tumor was resected; G: Microscopic appearance of caudate inflammatory pseudotumor-like follicular dendritic cell sarcoma (×200); H: Positive CD21 staining by immunohistochemistry (×200). Left approach to laparoscopic caudate perivascular epithelioid cell neoplasm lobectomy. A and B: The tumor was located at the Spiegel’s lobe; C: Isolation of the caudate lobe from left side; D: Dissection of the feeding portal pedicle of the caudate lobe (arrow P); E: Isolation of the tumor (arrow T) and dissection of short hepatic vein (arrow SHV); F: Surgical area after the tumor was resected; G: Microscopic appearance of caudate perivascular epithelioid cell neoplasm (×200); H: Positive HMB-45 staining by immunohistochemistry (×200).

Surgical procedures

The isolated caudate resection in open surgery procedures was performed as previously described[7].

Basic surgical techniques for laparoscopic isolated resection of the caudate lobe

The patient was placed in a supine position. Pneumoperitoneum was established at 13 mmHg. The patient’s central venous pressure was maintained at < 5 mmHg. Five port sites were used during the surgery. A 30-degree laparoscope was inserted through the central 12-mm port site under the umbilicus. Then, a 12-mm trocar was inserted subxiphoid, and two trocars (12 mm) were placed on the right and left midclavicular line subcostally. Two trocars (5 mm) are sited on the right and left anterior axillary line. The patient was tilted to the reverse Trendelenburg position. A complete laparoscopic examination of the abdominal contents, including laparoscopic liver ultrasonography, was performed to exclude undetected lesions or metastases. No inflow or outflow control of the liver was set during the surgery. The liver parenchyma was transected with a Harmonic scalpel.

Right and left combined approach

The liver was mobilized from both sides. The caudate lobe was retracted upward, and the short hepatic veins were identified, dissected, and divided from the right side before the dorsal trunks of the major hepatic veins were exposed (Figure 1C). After the portal pedicles of the caudate lobe were divided, the liver parenchyma was dissected from the caudal to the cranial aspects (Figure 1D). The liver dissection started from both sides and met at the cranial part of the caudate (Figure 1E and F).

Left approach

The left triangular ligament was divided. The liver was lifted upward with the subxiphoid trocar. The gastrohepatic ligament and left vena cava ligament were then divided. The caudate lobe was retracted to the right, and the short hepatic veins were identified, dissected, and divided. The cranial part of the caudate lobe was dissected carefully from the major hepatic veins (Figure 2C, E). The caudate lobe was then retracted anteriorly and caudally, and the portal pedicles going toward the caudate lobe were identified, dissected free, and divided (Figure 2D). The hepatic transection started from the inferior part from the caudal to the cranial aspects along the IVC (Figure 2F). All intraoperative parameters, including duration of vascular clamping, blood loss with subsequent intraoperative blood transfusion, and duration of surgery, were recorded. The overall surgical policy was to attempt radical anatomic resection while sparing the greatest amount of liver parenchyma feasible.

Statistical analysis

Continuous variables are reported as the mean and standard deviation and were compared by a Student’s t-test. P values < 0.05 were considered significant. Statistical review was performed by a biomedical statistician.

RESULTS

The characteristics of all 11 patients are detailed in Tables 1 and 2. Laparoscopic isolated caudate lobe resection was completed in all three patients without conversion to an open approach. The diagnoses of these three patients were PEComa (patient Nos. 10 and 11) and IPT-like FDC sarcoma (patient No. 9). The pathologic examination of patient No. 9 revealed localized spindle cell proliferation with cellular atypia surrounded by lymphocytes and plasma cells (Figure 1G). The immunohistochemistry staining showed that the spindle cells were positive for CD21 (Figure 1H), CD23, and CD35. Many EBV-positive spindle cells were identified by EBV-encoded small RNA in situ hybridization. The pathologic examination of patient No. 10 showed nodularly and trabecularly distributed epithelioid cells composed of thick-walled blood vessels, smooth muscle cells, and adipose cells (Figure 2G). The tumor cells were positive for HMB-45 (Figure 2H) and melan-A on immuno-histochemical staining.
Table 1

Clinical data

Patient No.GenderAgeDiagnosisTumor size (cm)
1Male42HCC1 × 1
2Male62HCC5 × 4
3Male52HCC2 × 1.5
4Male51HCC4 × 3
5Male44HCC8 × 4
6Female32FNH5 × 3
7Female52HCC2 × 2
8Male46HCC1 × 1
9Female32IPT-like FDC sarcoma3 × 3
10Female46PEComa2 × 1.5
11Female50PEComa1.8 × 1.3

HCC: Hepatocellular carcinoma; FNH: Focal nodular hyperplasia; PEComa: Perivascular epithelioid cell neoplasm; IPT-like FDC sarcoma: Inflammatory pseudotumor-like follicular dendritic cell sarcoma.

Table 2

Surgical data

Patient No.Surgical procedurePringle maneuverBlood loss (mL)Operation time (min)ComplicationsTime to removal of drainage tube (d)Postoperative hospital stay (d)
1LeftNo50135None212
2RightNo300150None611
3CombinedNo500375Pleural effusion2327
4LeftNo200270None912
5LeftNo500620Diarrheal514
6LeftNo1000265Pneumonia610
7LeftNo200130None513
8LeftNo200173None1025
9LeftNo100193None37
10CombinedYes200229Pleural effusion46
11LeftNo100255None36
Clinical data HCC: Hepatocellular carcinoma; FNH: Focal nodular hyperplasia; PEComa: Perivascular epithelioid cell neoplasm; IPT-like FDC sarcoma: Inflammatory pseudotumor-like follicular dendritic cell sarcoma. Surgical data The intermittent Pringle’s maneuver was applied in one of three patients. The blood loss ranged from 100 mL to 200 mL, and no blood transfusions were required. The abdominal drainage was removed within 4 d in all cases. There were no signs of hemodynamic instability during surgery, and none of the patients required open conversion. The postoperative courses were uneventful for all patients. All patients were able to tolerate liquids on the second postoperative day, and no biliary complications were encountered. All surgical margins were negative. The patients were alive and free of disease during a median follow-up period of 8 mo. The postoperative hospital stay was shorter in the laparoscopy group than in the open surgery group (6.3 ± 0.3 d vs 15.5 ± 2.3 d, P = 0.006). The blood loss (133 ± 33 mL vs 368 ± 105 mL, P = 0.22), operation time (225 ± 18 min vs 264 ± 59 min, P = 0.71), time to removal of drainage tube (3.3 ± 0.3 d vs 8.2 ± 2.3 d, P = 0.23), and occurrence of complications (3/8 vs 1/3, P = 0.72) were comparable between the two groups (Table 3).
Table 3

Results of statistical analysis

Open surgeryLaparoscopic surgeryP
Blood loss (mL)368 ± 105133 ± 330.22
Operation time (min)264 ± 59225 ± 180.71
Complication3/81/30.72
Time to removal of drainage tube (d)8.2 ± 2.33.3 ± 0.30.23
Postoperative hospital stays (d)15.5 ± 2.36.3 ± 0.30.006
Results of statistical analysis

DISCUSSION

PEComa is defined as a mesenchymal tumor composed of histologically and immunohistochemically distinctive perivascular epithelioid cells[8]. ITP-like FDC sarcoma is another rare hepatic mesenchymal tumor characterized by a mixture of chronic inflammatory cells and variable numbers of spindle cells with vesicular nuclei and distinct nucleoli[9]. Both of these tumors are considered either malignant or potentially malignant based on the histology features. Aside from hemangiomas, mesenchymal tumors are relatively uncommon in the liver, especially in the caudate lobe. Surgical treatment remains the mainstay of treatment. However, the optimal surgical procedures have not been defined due to limited experience. Caudate lobe resection is technically challenging due to the unique anatomical location. Local excision of the caudate lobe is technically demanding and requires different surgical strategies for each individual case. There are currently only a limited number of reports on laparoscopic caudate lobe resection. Our study represents the first series reporting the results of laparoscopic caudate lobe resection for rare hepatic mesenchymal neoplasms and an analysis comparing other lesions in the caudate lobe resected by open surgery. Our results suggest that laparoscopic caudate resection can be safely performed for mesenchymal neoplasms without open conversion or patient death. Accumulating evidence suggests that, in addition to its role as a staging tool, laparoscopic liver resection provides better quality of care, improves patient outcomes by minimizing blood loss and postoperative pain or morbidity, and shortens hospital stay relative to open surgery[10,11]. These findings are consistent with our results. The major risk for laparoscopic caudate resection is massive bleeding from major vessels. A combination of well-controlled central venous pressure and skilled suture techniques permitted management of major hepatic vein injury while dissecting the attachment in one of our patients, and no conversions or severe complications occurred. The reported oncologic control of malignant hepatic tumors by laparoscopic hepatectomy in many series has demonstrated comparable results versus the open approach. The 3- and 5-year survival rates reported for hepatocellular carcinoma[12] and colorectal cancer metastases[13] are comparable between laparoscopic hepatectomy and open hepatic resection. However, both PEComa and ITP-like FDC sarcoma are extremely rare mesenchymal tumors reported in only sporadic cases. Several research studies have emphasized that a safe surgical margin is associated with improved survival in patients with malignant hepatic mesenchymal tumors[14,15]. The overall surgical policy for malignant or potentially malignant mesenchymal tumors is to obtain a negative margin. Our study emphasizes several issues that might improve radical laparoscopic caudate resection. First, laparoscopic ultrasound should be used during the procedure to provide a precise evaluation of tumor location and its relationship with the adjacent vascular structures. Second, a retrohepatic tunnel should be accessed with priority. The laparoscopic surgical field is visualized from the caudal side to the cranial side and has significant advantages because it provides an excellent view and access to the retrohepatic tunnel along the IVC. This allows the short hepatic veins to be meticulously dissected and divided. The dissection of the dorsal part of the caudate lobe provides more space for safely dissecting cranial attachments from the major hepatic veins. Moreover, different surgical approaches should be considered based on tumor location. In the current series, the left approach was used in a patient with tumors located in the Spiegel portions, and the combined approach was used in the other two patients with tumors located in the paracaval portions. It has been widely proposed to use hepatic vascular control in open hepatic caudate lobectomy to reduce hemorrhage and vascular dissemination. However, this might not be necessary in laparoscopic caudate resection. Laparoscopy provides a clear visual image and access to the retrohepatic space, which improves precise dissection and efficient hemostasis without frequent retraction of the liver. In addition, the intra-abdominal pressure can be increased to 15 mmHg to balance the central venous pressure. Laparoscopic caudate resection should be applied in selected patients. Surgeons should consider the risk of massive bleeding from major vessels such as the IVC or middle hepatic vein associated with the anatomical location of the caudate tumor. The limitations of the present series include the limited number of patients who underwent laparoscopic resection and the relative heterogeneity of the tumors. There were no cases of PEComa or IPT-like FDC sarcoma resected by open surgery in our study. Additionally, the morbidity of these mesenchymal neoplasms makes it difficult to compare the long-term outcomes of the two different surgical approaches. Another limitation of our study is that laparoscopic caudate lobe resection might be indicated for only selected patients with small tumors. In conclusion, PEComa and ITP-like FDC sarcoma are both extremely rare mesenchymal neoplasms. Our data indicate that laparoscopic isolated caudate lobectomy for mesenchymal tumors is a safe and feasible procedure with acceptable perioperative results.

ARTICLE HIGHLIGHTS

Research background

Mesenchymal tumors such as perivascular epithelioid cell neoplasm (PEComa) and inflammatory pseudotumor-like follicular dendritic cell sarcoma (IPT-like FDC sarcoma) are very uncommon neoplasms in the liver, especially in the caudate lobe. Laparoscopic resection of such tumors in the caudate lobe has not been reported.

Research motivation

There is no report about laparoscopic resection of the rare hepatic mesenchymal neoplasms in the caudate lobe, and we wanted to explore the feasibility of laparoscopic resection of such tumors in the caudate lobe.

Research objectives

To assess the safety and feasibility of laparoscopic resection of rare caudate neoplasms like PEComa and IPT-like FDC sarcoma compared with open surgery.

Research methods

We analyzed the hospital stay duration, blood loss, operation time, time to removal of drainage tube, and occurrence of complications between the laparoscopic and open surgery groups.

Research results

The postoperative duration of hospital stay was significantly shorter in laparoscopic group, while the operation time, blood loss, time to removal of drainage tube, and occurrence of complications were comparable between the two groups.

Research conclusions

Laparoscopic resection of rare mesenchymal neoplasms like PEComa and IPT-like FDC sarcoma by isolated caudate lobectomy is safe and feasible.

Research perspectives

Our research indicates that laparoscopic caudate lobectomy is a prospective way to handle rare tumors in the caudate lobe.
  15 in total

1.  Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma.

Authors:  Lan Li; Yong-Hong Shi; Zhi-Juan Guo; Tian Qiu; Lei Guo; Hong-Ying Yang; Xun Zhang; Xin-Ming Zhao; Qin Su
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

2.  A Left-Sided, Purely Laparoscopic Approach for Anatomic Caudate Hepatectomy: A Single-Center Experience.

Authors:  Xiujun Cai; Jie Zhao; Yifan Wang; Hong Yu; Xiao Liang; Renan Jin; Ning Meng; Jiang Chen
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2016-01-08       Impact factor: 1.878

Review 3.  Surgical approach for hepatic caudate lobectomy: Review of 401 cases.

Authors:  Eleazar Chaib; Marcelo Augusto F Ribeiro; Francisco de S Collet E Silva; William A Saad; Ivan Cecconello
Journal:  J Am Coll Surg       Date:  2006-11-13       Impact factor: 6.113

4.  Laparoscopic liver resection of hepatocellular carcinoma.

Authors:  Hironori Kaneko; Sumito Takagi; Yuichiro Otsuka; Masaru Tsuchiya; Akira Tamura; Toshio Katagiri; Tetsuya Maeda; Tadaaki Shiba
Journal:  Am J Surg       Date:  2005-02       Impact factor: 2.565

Review 5.  Totally laparoscopic caudate lobe resection: technical aspects and literature review.

Authors:  Enrico Gringeri; Riccardo Boetto; Domenico Bassi; Francesco E D'Amico; Marina Polacco; Maurizio Romano; Stefania Barbieri; Paolo Feltracco; Marcello Spampinato; Giacomo Zanus; Umberto Cillo
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2014-12       Impact factor: 1.719

6.  Evaluation of 300 minimally invasive liver resections at a single institution: less is more.

Authors:  Alan J Koffron; Greg Auffenberg; Robert Kung; Michael Abecassis
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

7.  Isolated laparoscopic resection of the hepatic caudate lobe: surgical technique and a report of 2 cases.

Authors:  Jean-Louis Dulucq; Pascal Wintringer; Cesare Stabilini; Ahmad Mahajna
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2006-02       Impact factor: 1.719

8.  Oncologic results of laparoscopic versus open hepatectomy for colorectal liver metastases in two specialized centers.

Authors:  Denis Castaing; Eric Vibert; Luana Ricca; Daniel Azoulay; Rene Adam; Brice Gayet
Journal:  Ann Surg       Date:  2009-11       Impact factor: 12.969

Review 9.  Imaging features of rare mesenychmal liver tumours: beyond haemangiomas.

Authors:  Rajesh Thampy; Khaled M Elsayes; Christine O Menias; Perry J Pickhardt; Hyunseon C Kang; Sandeep P Deshmukh; Kareem Ahmed; Brinda Rao Korivi
Journal:  Br J Radiol       Date:  2017-08-02       Impact factor: 3.039

Review 10.  Uncommon liver tumors: Case report and literature review.

Authors:  Chia-Hung Wu; Nai-Chi Chiu; Yi-Chen Yeh; Yu Kuo; Sz-Shian Yu; Ching-Yao Weng; Chien-An Liu; Yi-Hong Chou; Yi-You Chiou
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

View more
  1 in total

1.  Safety and feasibility for laparoscopic versus open caudate lobe resection: a meta-analysis.

Authors:  Zigang Ding; Lingpeng Liu; Bangran Xu; Yong Huang; Hu Xiong; Dilai Luo; Mingwen Huang
Journal:  Langenbecks Arch Surg       Date:  2021-01-06       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.